Insider · CIK 0001263499
Richard W Dugan
Files at VNDA (Vanda Pharmaceuticals Inc.). First filing -, latest -.
In brief
Richard W Dugan files SEC Form 4 as director at VNDA (Vanda Pharmaceuticals Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Richard W Dugan has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 4, 2026 | VNDA Vanda Pharmaceuticals Inc. | AGrant or award Common Stock | +41,600 | $0.00 | $0 | 219,054 | Jun 8, 2026 |
| Jun 5, 2025 | VNDA Vanda Pharmaceuticals Inc. | AGrant or award Common Stock | +59,225 | $0.00 | $0 | 177,454 | Jun 9, 2025 |
Questions about Richard W Dugan
Answered from the filings on this page, as of the latest one.
Is Richard W Dugan buying or selling?
Richard W Dugan has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Richard W Dugan's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Richard W Dugan has 0.
Where does Richard W Dugan file Form 4?
Richard W Dugan has filed Form 4 at VNDA (Vanda Pharmaceuticals Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.